Description
Market Report Coverage – Nutrigenomics
Market Segmentation
• Application – Women’s Health, Digestive Health, Immune Health, and Others
• Type – by Product (Probiotics and Prebiotics and Dietary Supplements) and by Service (Nutrigenomics Genetic Testing For Clinical Purpose and Nutrigenomics Genetic Testing For Research)
Regional Segmentation
• North America – U.S. and Canada
• Europe – U.K., Germany, France, Italy, Spain
• Asia-Pacific – Japan, China, India, Australia, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World
Market Growth Drivers
• Rising Advancement in Genomics Technology
• Increasing Incidence of Lifestyle-Related Diseases
• Increasing Demand for Preventive Medication Through Personalized Nutrition
• Limited Efficacy Rate of Drugs
Market Challenges
• Insufficient Application-Based Research Hindering Market Pull
• Lack of Awareness Regarding the Usage of Probiotics and Prebiotics
• Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on Nutrigenomics
Market Opportunities
• Massive Scope for Phenomenal Profits Through Venturous Investments
• Integrative Industry-Academia Collaboration
• Rise of Next-Generation Probiotics
• Shifting of Reimbursement Policies Toward Enhanced Genetics Coverage
Key Companies Profiled
BioGaia, DuPont de Nemours, Inc., Nutrigenomix Inc., MedGenome, Garden of Life, LLC, Ingredion Incorporated, Jarrow Formulas Inc., geneOmbio, GX Sciences, Inc., DNAfit, Yakult Honsha Co., Ltd., Koninklijke DSM N.V., XCODE Life
Key Questions Answered in this Report:
• What are the most common genetic conditions that have a significant role of nutrition metabolism?
• What emerging trends are being followed by the companies in the global nutrigenomics market?
• How are the key market players performing research investments in the respective market?
• What are the major strategies opted by the key players for advancing in the global nutrigenomics market?
• What are the regulations pertaining to the global nutrigenomics market among different regions and their impact on respective markets?
• What are the initiatives implemented by different government bodies regulating the development and commercialization of nutrigenomic tests and associated platforms?
• How has COVID-19 impacted the global nutrigenomics market?
• How will the urgency of the pandemic influence the global nutrigenomics market?
• Which are the leading companies dominating the global nutrigenomics market?
• What is the reimbursement scenario of the tests offered in the global nutrigenomics market?
• Based on the application type, which global nutrigenomics market application is anticipated to witness a massive rise in demand during the forecast period 2021-2031?
• How is each segment of the global nutrigenomics market expected to grow during the forecast period, and what revenue is expected to be generated by each of the segments by the end of 2031?
• How is the global nutrigenomics industry anticipated to evolve during the forecast period 2021-2031?
• What are the leading trends and consumer preferences witnessed in the global nutrigenomics market?
Market Overview
The concept of nutrigenomics has emerged with an idea to assist an individual in achieving a lasting dietary behavior change that is beneficial for health. Nutrigenomics aims to elucidate the impact of diet on human health. The bioactive food compounds can interact with genes affecting the transcription factors, protein expression, and metabolite production. The study of these complex interactions requires the development of advanced analytical approaches combined with bioinformatics. The advancements in omics technology have opened gateways to deliver the biomarkers for health and comfort, disclose early indicators for a disease disposition, assist in differentiating dietary responders from non-responders, and, last but not least, discover bioactive, beneficial food components.
Further, the increasing rate of obesity and lifestyle-related diseases has led to the rise in the focus on diet-related changes in metabolism and gene. Additionally, the evolution of technology has increased the pace of the market advancements in nutrigenomics.
The segments included in the comprehensive market study are:
• by Application
• by Type
o by Product
o by Service
• by Region
The global nutrigenomics market, based on type, is further segmented into product (dietary usage) and by service (nutrigenomic genetic testing). The dietary usage products involve probiotics and prebiotics offered by the company that are impacting the genome directly or indirectly. Further, the genetic testing services in nutrigenomics involved offers insights regarding the diet that has an impact on gene.
Competitive Landscape
The global nutrigenomics market consists of numerous large- and small-scale manufacturers and service providers. Presently, with the increasing rate of molecular advancements and the rise in the adoption of genetic tests, there has been an expansion of opportunities for the nutrigenomics market. Some of the strategies opted by the key players within the market are new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.
In the five years (January 2017- June 2021), the market witnessed 23 product offerings, 25 synergistic activities, six funding and investments, and five business expansions. The increasing awareness for genetic testing and nutrigenomic diet such as prebiotic and probiotic food has majorly attributed to the growing prominence for nutrigenomics.
On the basis of region, North America holds the largest share of the nutrigenomics market owing to improved health consciousness, better genetic testing facilities, and favorable regulatory policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Global Direct-to-Consumer Genetic Testing Market: Focus on Direct-to-Consumer Genetic Testing Market by Product Type, Distribution Channel, 15 Countries Mapping, and Competitive Landscape – Analysis and Forecast, 2021-2031
Table of Contents
1 Nutrigenomics: Product Definition
1.1 Inclusion:
1.2 Exclusion:
1.2.1 Key Questions Answered by the Research Study
2 Research Methodology
2.1 Primary Data Sources
2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Assumptions and Limitations
3 Global Nutrigenomics Market: An Overview
3.1 Evolution of Nutrigenomics as Personalized Food
3.2 Nutrigenetics and Nutrigenomics: Focusing on Gene and Diet Interaction
3.3 Scenario of Genetic Testing in Nutrigenomics
3.4 Impact of COVID-19 on Global Nutrigenomics Market
3.5 COVID-19 Affecting Supply Chain of Nutrigenomics Market
3.6 Interruption in Research and Clinical Development and Commercial Operation
3.6.1 Research and Clinical Development
3.6.2 Commercial Operation and Access
3.7 Navigating Crisis Recovery and Looking to the Future
4 Global Nutrigenomics Market: Industry Analysis
4.1 Legal and Regulatory Framework
4.1.1 Legal Requirements and Framework in the U.S.
4.1.2 Legal Requirements and Framework in Europe
4.1.3 Legal Requirements and Framework in Asia-Pacific
4.1.3.1 Japan
4.1.3.2 China
4.2 Patent Landscape
5 Global Nutrigenomics Market: Market Dynamics
5.1 Market Drivers
5.1.1 Rising Advancement in Genomics Technology
5.1.2 Increasing Incidence of Lifestyle-Related Diseases
5.1.3 Increasing Demand for Preventive Medication Through Personalized Nutrition
5.1.4 Limited Efficacy Rate of Drugs
5.2 Market Restraints
5.2.1 Insufficient Application-Based Research Hindering Market Pull
5.2.2 Lack of Awareness Regarding the Usage of Probiotics and Prebiotics
5.2.3 Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on Nutrigenomics
5.3 Market Opportunities
5.3.1 Massive Scope for Phenomenal Profits Through Venturous Investments
5.3.2 Integrative Industry-Academia Collaboration
5.3.3 Rise of Next-Generation Probiotics
5.4 Shifting of Reimbursement Policies Toward Enhanced Genetics Coverage
6 Global Nutrigenomics Market: Competitive Landscape
6.1 Key Developments and Strategies
6.2 New Offerings
6.3 Partnerships and Alliances
6.4 Funding & Investment and Business Expansion
6.5 Merger and Acquisition
6.6 Other Strategies
6.7 Market Share Analysis
6.8 Growth-Share Analysis
7 Global Nutrigenomics Market, by Application
7.1 Overview
7.2 Women’s Health
7.3 Digestive Health
7.4 Immune Health
7.5 Others
8 Global Nutrigenomics Market, by Type
8.1 Global Nutrigenomics Market, by Product
8.1.1 Probiotics
8.1.2 Prebiotics and Dietary Supplement
8.2 Global Nutrigenomics Market, by Service
8.2.1 Nutrigenomics Genetic Testing (For Clinical Purpose)
8.2.2 Nutrigenomics Genetic Testing (For Research)
9 Global Nutrigenomics Market, by Region
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 Italy
9.3.3 France
9.3.4 U.K.
9.3.5 Spain
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest-of-Asia-Pacific
9.5 Latin America
9.5.1 Brazil
9.6 Mexico
9.7 Rest-of-Latin America
9.8 Rest-of-the-World
10 Company Profiles
10.1 Overview
10.2 BioGaia
10.2.1 Company Overview
10.2.2 Role of Bioagia in the Global Nutrigenomics Market
10.2.3 Financials
10.2.4 SWOT Analysis
10.3 DuPont de Nemours, Inc.
10.3.1 Company Overview
10.3.2 Role of DuPont de Nemours, Inc. in the Global Nutrigenomics Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 Nutrigenomix Inc.
10.4.1 Company Overview
10.4.2 Role of Nutrigenomix Inc. in the Global Nutrigenomics Market
10.4.3 SWOT Analysis
10.5 MedGenome
10.5.1 Company Overview
10.5.2 Role of MedGenome in the Global Nutrigenomics Market
10.5.3 SWOT Analysis
10.6 Garden of Life, LLC
10.6.1 Company Overview
10.6.2 Role of Garden of Life, LLC in the Global Nutrigenomics Market
10.6.3 SWOT Analysis
10.7 Ingredion Incorporated
10.7.1 Company Overview
10.7.2 Role of Ingredion Incorporated in the Global Nutrigenomics Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 Jarrow Formulas Inc.
10.8.1 Company Overview
10.8.2 Role of Jarrow Formulas Inc. in the Global Nutrigenomics Market
10.8.3 SWOT Analysis
10.9 geneOmbio
10.9.1 Company Overview
10.9.2 Role of geneOmbio in the Global Nutrigenomics Market
10.9.3 SWOT Analysis
10.1 GX Sciences, Inc.
10.10.1 Company Overview
10.10.2 Role of GX Sciences, Inc.in the Global Nutrigenomics Market
10.10.3 SWOT Analysis
10.11 DNAfit
10.11.1 Company Overview
10.11.2 Role of DNAfit in the Global Nutrigenomics Market
10.11.3 SWOT Analysis
10.12 Yakult Honsha Co., Ltd.
10.12.1 Company Overview
10.12.2 Role of Yakult Honsha Co., Ltd. in the Global Nutrigenomics Market
10.12.3 Financials
10.12.4 SWOT Analysis
10.13 Koninklijke DSM N.V.
10.13.1 Company Overview
10.13.2 Role of Koninklijke DSM N.V. in the Global Nutrigenomics Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 XCODE Life
10.14.1 Company Overview
10.14.2 Role of XCODE Life in the Global Nutrigenomics Market
10.14.3 SWOT Analysis
List of Tables
Table 3.1: Impact of SNP and Nutrition Health
Table 7.1: Documented Microbial Associations with Disease Status
List of Figures
Figure 1: Prevalence of Obesity in the U.S.
Figure 2: Global Nutrigenomics Market, 2020-2031
Figure 3: Impact Analysis
Figure 4: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020
Figure 1.1: Concept of Extended Nutrigenomics
Figure 1.2: Global Nutrigenomics Market Segmentation
Figure 2.1: Global Nutrigenomics Market Research Methodology
Figure 2.2: Primary Research Methodology
Figure 2.3: Bottom-up Approach
Figure 3.1: Global Nutrigenomics Market, 2020-2031
Figure 3.2: Global Nutrigenomics Market, by Product (Dietary Usage), 2020-2031
Figure 3.3: Global Nutrigenomics Market, by Service (Nutrigenomic Genetic Testing), 2020-2031
Figure 3.4: Anatomy of Gene Diet Interaction
Figure 3.5: Positive and Negative Impact of COVID-19 on Global Nutrigenomics Market
Figure 3.6: Pre-COVID-19 and Post-COVID-19 Scenario of Global Nutrigenomics Market
Figure 3.7: Measure to Navigate Crisis Recovery
Figure 4.1: Guidelines for the Evaluation of Probiotics for Food Use
Figure 4.2: Number of Patents (by Year), 2017-2020
Figure 5.1: Impact Analysis
Figure 5.2: Diet and Disease Linkage
Figure 5.3: Deaths Owing to Non-Communicable Disorders, 2015-2019
Figure 6.1: Share of Key Developments and Strategies, January 2018-June 2021
Figure 6.2: Product Offering Share (by Company), January 2018-June 2021
Figure 6.3: Partnerships and Alliances Activities Share (by Company), January 2018- June 2021
Figure 6.4: Funding & Investment and Business Expansion (by Company), January 2018-June 2021
Figure 6.5: Mergers and Acquisitions (by Company), January 2018-June 2021
Figure 6.6: Other Activities (by Company), January 2018-June 2021
Figure 6.7: Global Nutrigenomics Market Share Analysis, by Dietary Usage 2020
Figure 6.8: Global Nutrigenomics Market Share Analysis , by Nutrigenomic Testing Market, 2020
Figure 6.9: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020
Figure 7.1: Share of Global Nutrigenomics Market (by Application), $Million, 2020-2031
Figure 7.2: Inter-Related Factors Governing Women’s Health
Figure 7.3: Global Nutrigenomics Market, by Women’s Health, 2020-2031
Figure 7.4: Global Nutrigenomics Market, by Digestive Health, 2020-2031
Figure 7.5: Global Nutrigenomics Market, by Immune Health, 2020-2031
Figure 7.6: Global Nutrigenomics Market, by Other Applications, 2020-2031
Figure 8.1: Global Nutrigenomics Market, by Product, 2020-2031
Figure 8.2: Global Nutrigenomics Market, by Probiotics, 2020-2031
Figure 8.3: Global Nutrigenomics Market, by Prebiotics and Dietary Supplement, 2020-2031
Figure 8.4: Effect of genes on different aspects of health
Figure 8.5: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Clinical Purpose), 2020-2031
Figure 8.6: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Research Purpose), 2020-2031
Figure 9.1: North America Nutrigenomics Market, 2020-2031
Figure 9.2: North America: Market Dynamics
Figure 9.3: North America Nutrigenomics Market (by Country), 2020-2031
Figure 9.4: U.S. Nutrigenomics Market, 2020-2031
Figure 9.5: Canada Nutrigenomics Market, 2020-2031
Figure 9.6: Europe Nutrigenomics Market, 2020-2031
Figure 9.7: Europe: Market Dynamics
Figure 9.8: Europe Nutrigenomics Market (by Country), 2020-2031
Figure 9.9: Germany Nutrigenomics Market, 2021-2031
Figure 9.10: Italy Nutrigenomics Market, 2020-2031
Figure 9.11: France Nutrigenomics Market, 2020-2031
Figure 9.12: U.K. Nutrigenomics Market, 2020-2031
Figure 9.13: Spain Nutrigenomics Market, 2020-2031
Figure 9.14: Asia-Pacific Nutrigenomics Market, 2020-2031
Figure 9.15: Asia-Pacific: Market Dynamics
Figure 9.16: Asia-Pacific Nutrigenomics Market (by Country), 2020-2031
Figure 9.17: China Nutrigenomics Market, 2021-2031
Figure 9.18: Japan Nutrigenomics Market, 2020-2031
Figure 9.19: India Nutrigenomics Market, 2021-2031
Figure 9.20: Australia Nutrigenomics Market, 2020-2031
Figure 9.21: Rest-of-Asia-Pacific Nutrigenomics Market, 2020-2031
Figure 9.22: Latin America Nutrigenomics Market, 2020-2031
Figure 9.23: Latin America: Market Dynamics
Figure 9.24: Latin America Nutrigenomics Market (by Country), 2020 and 2031
Figure 9.25: Brazil Nutrigenomics Market, 2020-2031
Figure 9.26: Mexico Nutrigenomics Market, 2020-2031
Figure 9.27: Rest-of-Latin America Nutrigenomics Market, 2020-2031
Figure 9.28: Rest-of-the-World Nutrigenomics Market, 2020-2031
Figure 10.1: Shares of Key Company Profiles
Figure 10.2: BioGaia: Overall Product Offerings
Figure 10.3: BioGaia: Overall Financials, 2018-2020
Figure 10.4: BioGaia: Revenue (by Region), 2018-2020
Figure 10.5: BioGaia: R&D Expenditure, 2018-2020
Figure 10.6: BioGaia: SWOT Analysis
Figure 10.7: DuPont de Nemours, Inc.: Overall Product Offerings
Figure 10.8: DuPont de Nemours, Inc.: Overall Financials, 2018-2020
Figure 10.9: DuPont de Nemours, Inc.: Revenue (by Region), 2018-2020
Figure 10.10: DuPont de Nemours, Inc.: R&D Expenditure, 2018-2020
Figure 10.11: DuPont de Nemours, Inc.: SWOT Analysis
Figure 10.12: Nutrigenomix Inc.: Overall Product Offerings
Figure 10.13: Nutrigenomix Inc.: SWOT Analysis
Figure 10.14: MedGenome: Overall Product Portfolio
Figure 10.15: MedGenome: SWOT Analysis
Figure 10.16: Garden of Life, LLC: Overall Product Portfolio
Figure 10.17: Garden of Life, LLC: SWOT Analysis
Figure 10.18: Ingredion Incorporated: Overall Product Offerings
Figure 10.19: Ingredion Incorporated: Overall Financials, 2018-2020
Figure 10.20: Ingredion Incorporated: Revenue (by Segment), 2018-2020
Figure 10.21: Ingredion Incorporated: Revenue (by Region), 2018-2020
Figure 10.22: Ingredion Incorporated: R&D Expenditure, 2018-2020
Figure 10.23: Ingredion Incorporated: SWOT Analysis
Figure 10.24: Jarrow Formulas Inc.: Overall Product Portfolio
Figure 10.25: Jarrow Formulas Inc.: SWOT Analysis
Figure 10.26: geneOmbio: Product Portfolio for Nutrigenomics Market
Figure 10.27: geneOmbio.: SWOT Analysis
Figure 10.28: GX Sciences, Inc.: Overall Product Offerings
Figure 10.29: GX Sciences, Inc.: SWOT Analysis
Figure 10.30: DNAfit: Overall Product Offerings
Figure 10.31: DNAfit: SWOT Analysis
Figure 10.32: Yakult Honsha Co., Ltd.: Overall Product Offerings
Figure 10.33: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019
Figure 10.34: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019
Figure 10.35: Yakult Honsha Co., Ltd.: SWOT Analysis
Figure 10.36: Koninklijke DSM N.V.: Overall Product Offerings
Figure 10.37: Koninklijke DSM N.V.: Overall Financials, 2018-2020
Figure 10.38: Koninklijke DSM N.V.: Revenue (by Segment), 2018-2020
Figure 10.39: Koninklijke DSM N.V.: Revenue (by Region), 2018-2020
Figure 10.40: Koninklijke DSM N.V.: R&D Expenditure, 2018-2020
Figure 10.41: Koninklijke DSM N.V.: SWOT Analysis
Figure 10.42: XCODE Life: Overall Product Portfolio
Figure 10.43: XCODE Life: SWOT Analysis
